\-\ Texto\\:\\ \ \(0\)\
\-\ rapid\\ development\\ of\\ dropping\\ hematocrit\\.\ \(0\)\
\-\ patient\\ undergoing\\ continued\\ icu\\ support\\ at\\ the\\ time\\ of\\ case\\ compilation\\.\\ \\ the\\ standard\\ treatment\\ for\\ retinoic\\ acid\\ syndrome\\ is\\ 10mg\\ dexamethasone\\ iv\\ q12\\ hours\\ for\\ a\\ minimum\\ of\\ 3\\ days\\ \\(nicolls\\,\\ 1305\\)\\.\ \(0\)\
\-\ an\\ ap\\ portable\\ radiograph\\ of\\ the\\ chest\\ demonstrates\\ asymmetric\\,\\ bilateral\\,\\ diffuse\\ hazy\\ alveolar\\ consolidation\\ pattern\\ later\\ shown\\ with\\ bronchoscopy\\ to\\ be\\ the\\ result\\ of\\ diffuse\\ alveolar\\ hemorrhage\\.\\ \\ a\\ dual\\ lumen\\ endotracheal\\ tube\\ is\\ present\\ with\\ its\\ distal\\ segment\\ in\\ the\\ left\\ main\\ pulmonary\\ bronchus\\.\\ \\ axial\\ ct\\ image\\ of\\ the\\ chest\\ of\\ the\\ same\\ patient\\ demonstrating\\ ground\\ glass\\ air\\ space\\ filling\\ pattern\\ attributed\\ to\\ intra\\-alveolar\\ blood\\ as\\ discussed\\ above\\.\ \(0\)\
\-\ pulmonary\\ hemorrhage\\.\ \(1\)\
\-\ the\\ differential\\ diagnosis\\ of\\ pulmonary\\ hemorrhage\\ includes\\:\\ spontaneous\\ \\(thrombocytopenia\\,\\ hemophilia\\,\\ anticoagulation\\ therapy\\)\\,\\ trauma\\ \\(such\\ as\\ pulmonary\\ contusion\\)\\,\\ embolic\\ disease\\ \\(pulmonary\\ embolism\\,\\ fat\\ embolism\\)\\,\\ vasculidites\\ \\(autoimmune\\ such\\ as\\ goodpasture\\â\\€\\™s\\,\\ idiopathic\\ pulmonary\\ hemorrhage\\,\\ and\\ wegener\\â\\€\\™s\\ granulomatosis\\ and\\ infectious\\ such\\ as\\ gram\\ negative\\ bacteria\\,\\ influenza\\,\\ aspergillus\\,\\ and\\ mucormycosis\\)\\,\\ and\\ drugs\\ \\(for\\ example\\,\\ pencillamine\\)\\ \\(brant\\ and\\ helms\\,\\ 368\\)\\.\ \(0\)\
\-\ patient\\ with\\ known\\ acute\\ promyelocytic\\ leukemia\\ presents\\ with\\ acute\\ onset\\ hemoptysis\\.\ \(0\)\
\-\ see\\ factoid\\.\ \(59\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pulmonary\\:\\ 0\\.29365941713729404\ \(0\)\
\-\ alveolar\\:\\ 0\\.2528199042360745\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.21503689167706952\ \(0\)\
\-\ such\\:\\ 0\\.15494866080900366\ \(0\)\
\-\ embolism\\:\\ 0\\.1455816414971889\ \(0\)\
\-\ as\\:\\ 0\\.12902869824241173\ \(0\)\
\-\ retinoic\\:\\ 0\\.12840848211105732\ \(0\)\
\-\ nicolls\\:\\ 0\\.12840848211105732\ \(0\)\
\-\ vasculidites\\:\\ 0\\.12840848211105732\ \(0\)\
\-\ pencillamine\\:\\ 0\\.12840848211105732\ \(0\)\
\-\ promyelocytic\\:\\ 0\\.12840848211105732\ \(0\)\
\-\ the\\:\\ 0\\.12817339382816686\ \(0\)\
\-\ of\\:\\ 0\\.12570632041494983\ \(0\)\
\-\ 1305\\:\\ 0\\.12270115988970104\ \(0\)\
\-\ pattern\\:\\ 0\\.11989473138175526\ \(0\)\
\-\ dropping\\:\\ 0\\.11865175033026766\ \(0\)\
\-\ compilation\\:\\ 0\\.11865175033026766\ \(0\)\
\-\ goodpasture\\:\\ 0\\.11551078425575108\ \(0\)\
\-\ mucormycosis\\:\\ 0\\.11551078425575108\ \(0\)\
\-\ q12\\:\\ 0\\.11294442810891137\ \(0\)\
\-\ 368\\:\\ 0\\.11294442810891137\ \(0\)\
\-\ minimum\\:\\ 0\\.11077460490385128\ \(0\)\
\-\ dexamethasone\\:\\ 0\\.10889501854947801\ \(0\)\
\-\ 10mg\\:\\ 0\\.1057540524749614\ \(0\)\
\-\ thrombocytopenia\\:\\ 0\\.10441246747481986\ \(0\)\
\-\ influenza\\:\\ 0\\.10441246747481986\ \(0\)\
\-\ hemophilia\\:\\ 0\\.1031876963281217\ \(0\)\
\-\ aspergillus\\:\\ 0\\.10206101609096346\ \(0\)\
\-\ diffuse\\:\\ 0\\.10070925572948004\ \(0\)\
\-\ brant\\:\\ 0\\.098284935285823\ \(0\)\
\-\ hazy\\:\\ 0\\.0974803741067654\ \(0\)\
\-\ helms\\:\\ 0\\.09671932451894115\ \(0\)\
\-\ endotracheal\\:\\ 0\\.09531055090170532\ \(0\)\
\-\ dual\\:\\ 0\\.09230428431017379\ \(0\)\
\-\ attributed\\:\\ 0\\.08982844930202448\ \(0\)\
\-\ autoimmune\\:\\ 0\\.08982844930202448\ \(0\)\
\-\ wegener\\:\\ 0\\.08982844930202448\ \(0\)\
\-\ bacteria\\:\\ 0\\.08894841347267389\ \(0\)\
\-\ granulomatosis\\:\\ 0\\.08852820350503333\ \(0\)\
\-\ bronchoscopy\\:\\ 0\\.08772364232597575\ \(0\)\
\-\ acute\\:\\ 0\\.08687257459117316\ \(0\)\
\-\ embolic\\:\\ 0\\.08659696208881748\ \(0\)\
\-\ icu\\:\\ 0\\.08555381912091566\ \(0\)\
\-\ gram\\:\\ 0\\.08555381912091566\ \(0\)\
\-\ portable\\:\\ 0\\.08522260410866621\ \(0\)\
\-\ bronchus\\:\\ 0\\.08489900391324053\ \(0\)\
\-\ chest\\:\\ 0\\.0847670755666791\ \(0\)\
\-\ acid\\:\\ 0\\.08338399591585556\ \(0\)\
\-\ hematocrit\\:\\ 0\\.08309962283886548\ \(0\)\
\-\ hemoptysis\\:\\ 0\\.08309962283886548\ \(0\)\
\-\ and\\:\\ 0\\.08295943922597401\ \(0\)\
\-\ glass\\:\\ 0\\.0807698434970969\ \(0\)\
\-\ drugs\\:\\ 0\\.08030060042693131\ \(0\)\
\-\ example\\:\\ 0\\.08007171752123482\ \(0\)\
\-\ discussed\\:\\ 0\\.07962482320710901\ \(0\)\
\-\ contusion\\:\\ 0\\.07898000870220301\ \(0\)\
\-\ patient\\:\\ 0\\.0783473687713108\ \(0\)\
\-\ ground\\:\\ 0\\.07816378072715598\ \(0\)\
\-\ support\\:\\ 0\\.07796691054518608\ \(0\)\
\-\ rapid\\:\\ 0\\.07467040710296774\ \(0\)\
\-\ standard\\:\\ 0\\.07451656963123515\ \(0\)\
\-\ anticoagulation\\:\\ 0\\.07451656963123515\ \(0\)\
\-\ consolidation\\:\\ 0\\.07421384853267415\ \(0\)\
\-\ leukemia\\:\\ 0\\.07334289105807582\ \(0\)\
\-\ for\\:\\ 0\\.07300999498400002\ \(0\)\
\-\ undergoing\\:\\ 0\\.07292682169601165\ \(0\)\
\-\ asymmetric\\:\\ 0\\.07225958832382978\ \(0\)\
\-\ lumen\\:\\ 0\\.07149853873600552\ \(0\)\
\-\ main\\:\\ 0\\.06997849190249894\ \(0\)\
\-\ spontaneous\\:\\ 0\\.06986809142631936\ \(0\)\
\-\ idiopathic\\:\\ 0\\.06791994191370959\ \(0\)\
\-\ development\\:\\ 0\\.06637955241957703\ \(0\)\
\-\ segment\\:\\ 0\\.06629398383657797\ \(0\)\
\-\ demonstrating\\:\\ 0\\.06620893228744752\ \(0\)\
\-\ continued\\:\\ 0\\.06579121651464923\ \(0\)\
\-\ infectious\\:\\ 0\\.06460766351908885\ \(0\)\
\-\ tube\\:\\ 0\\.06416076920496304\ \(0\)\
\-\ same\\:\\ 0\\.06351595470005703\ \(0\)\
\-\ with\\:\\ 0\\.06289071495572181\ \(0\)\
\-\ includes\\:\\ 0\\.06243784031402876\ \(0\)\
\-\ shown\\:\\ 0\\.062244574277144596\ \(0\)\
\-\ filling\\:\\ 0\\.06218073748493945\ \(0\)\
\-\ hours\\:\\ 0\\.061196861924831446\ \(0\)\
\-\ result\\:\\ 0\\.060111359645529695\ \(0\)\
\-\ its\\:\\ 0\\.05941412054164316\ \(0\)\
\-\ above\\:\\ 0\\.05792583539193094\ \(0\)\
\-\ ap\\:\\ 0\\.05764617079083538\ \(0\)\
\-\ later\\:\\ 0\\.05746276769386568\ \(0\)\
\-\ iv\\:\\ 0\\.05737195454947965\ \(0\)\
\-\ factoid\\:\\ 0\\.056075702884997324\ \(0\)\
\-\ space\\:\\ 0\\.05344756468481541\ \(0\)\
\-\ air\\:\\ 0\\.05251986978788646\ \(0\)\
\-\ radiograph\\:\\ 0\\.052297194138745985\ \(0\)\
\-\ differential\\:\\ 0\\.052171514834573544\ \(0\)\
\-\ known\\:\\ 0\\.051985075174426194\ \(0\)\
\-\ onset\\:\\ 0\\.05155941889657824\ \(0\)\
\-\ image\\:\\ 0\\.05135132235068312\ \(0\)\
\-\ days\\:\\ 0\\.05082992983443199\ \(0\)\
\-\ fat\\:\\ 0\\.04994817069600047\ \(0\)\
\-\ see\\:\\ 0\\.04994817069600047\ \(0\)\
\-\ negative\\:\\ 0\\.04970981335983401\ \(0\)\
\-\ syndrome\\:\\ 0\\.04840647835213027\ \(0\)\
\-\ time\\:\\ 0\\.04759261073401934\ \(0\)\
\-\ distal\\:\\ 0\\.046653134893791755\ \(0\)\
\-\ blood\\:\\ 0\\.046632015627181105\ \(0\)\
\-\ trauma\\:\\ 0\\.046632015627181105\ \(0\)\
\-\ axial\\:\\ 0\\.04638102552604229\ \(0\)\
\-\ therapy\\:\\ 0\\.04613443255869874\ \(0\)\
\-\ is\\:\\ 0\\.043978421724959665\ \(0\)\
\-\ bilateral\\:\\ 0\\.043153259658145926\ \(0\)\
\-\ diagnosis\\:\\ 0\\.041624130955458284\ \(0\)\
\-\ present\\:\\ 0\\.041201746787761596\ \(0\)\
\-\ case\\:\\ 0\\.040339113969381814\ \(0\)\
\-\ demonstrates\\:\\ 0\\.040339113969381814\ \(0\)\
\-\ to\\:\\ 0\\.040146964709277956\ \(0\)\
\-\ presents\\:\\ 0\\.03862582814832897\ \(0\)\
\-\ treatment\\:\\ 0\\.03824855964090711\ \(0\)\
\-\ disease\\:\\ 0\\.03370480393153141\ \(0\)\
\-\ be\\:\\ 0\\.03257229311566828\ \(0\)\
\-\ an\\:\\ 0\\.030704370334857352\ \(0\)\
\-\ ct\\:\\ 0\\.03056889297955269\ \(0\)\
\-\ at\\:\\ 0\\.030328271931225642\ \(0\)\
\-\ left\\:\\ 0\\.027390225746133343\ \(0\)\
\-\ in\\:\\ 0\\.019974680716063054\ \(0\)\
